• Differential Effects of Chuanxiong Cortex and Pith in CHD Th

  2026-07-09

  This study dissects the distinct chemical profiles and molecular mechanisms of the cortex and pith of Ligusticum chuanxiong rhizome in the context of coronary heart disease (CHD) prevention. By integrating SPME-GC×GC-MS and network pharmacology, the research demonstrates that these plant tissues harbor unique bioactive compounds and pathway targets, supporting tailored applications in cardiovascular therapeutics.

• Ibuprofen in Oncology: Mechanisms, Assay Optimization, and B

  2026-07-09

  Explore the multifaceted roles of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) in cancer research, with a focus on apoptosis induction, cell cycle arrest, and assay precision. This guide uniquely integrates bioavailability and protein-binding insights, advancing beyond protocol basics.

• ERAD-Engaging Chimeras Enable Rapid Degradation of TM Protei

  2026-07-08

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that selectively degrades transmembrane proteins by hijacking the ER-associated degradation (ERAD) pathway. This advance addresses key challenges in targeted protein degradation, offering high selectivity and efficacy with implications for cancer and membrane protein research.

• Sex Differences in Cannabinoid Withdrawal: Insights from WIN

  2026-07-08

  This study systematically characterizes somatic and anxiety-like behaviors during withdrawal from the synthetic cannabinoid agonist WIN 55,212-2 in male and female rats. The findings reveal qualitative sex differences in withdrawal behaviors, informing both endocannabinoid system research and the translational modeling of cannabinoid dependence.

• GPR35-KLF5 Circuitry Decodes Mucosal Damage for Epithelial R

  2026-07-07

  This study reveals a metabolic sensing mechanism in which GPR35 detects tryptophan metabolite signals in response to colonic injury, activating a KLF5-driven repair program via the PI3K-AKT-mTOR pathway. The findings clarify how intestinal epithelial cells orchestrate proliferation and migration after mucosal damage, providing new insights for ulcerative colitis research.

• Angiotensin (1-7): Applied Protocols and Research Innovation

  2026-07-07

  Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) is revolutionizing experimental workflows in anti-fibrotic, metabolic, and neuroprotective research by precisely modulating PI3K/AKT and ERK pathways. With validated protocols, high solubility, and peer-reviewed insights, APExBIO's reagent empowers translational scientists to bridge bench findings and clinical potential.

• Universal nPEC Method for Dual-Loaded Liposome Efficiency An

  2026-07-06

  This study introduces and validates a nanoparticle exclusion HPLC (nPEC) method as an accurate, robust, and universally applicable approach for determining encapsulation efficiency in dual-loaded liposomes, addressing the challenges posed by drugs with differing physicochemical properties. The findings provide a significant advance for researchers optimizing liposomal co-delivery systems, combination therapy protocols, and nanomedicine development.

• Pentoxifylline (SKU C3816): Reliable Solutions for Inflammat

  2026-07-06

  This article addresses real-world laboratory challenges in cell-based inflammation and immunomodulation assays, highlighting how Pentoxifylline (SKU C3816) from APExBIO offers reproducible, data-driven outcomes. We present scenario-driven Q&A blocks—grounded in literature and product evidence—to guide protocol optimization, data interpretation, and vendor selection for researchers working with this versatile phosphodiesterase inhibitor.

• KR-12 (human) TFA: Mechanisms, Benchmarks & Protocol Integra

  2026-07-05

  KR-12 human antimicrobial peptide is the smallest active fragment of LL-37 with a narrow, defined antimicrobial spectrum and unique copper-binding properties. Its activity is highly sequence-dependent, non-toxic to mammalian cells at working concentrations, and validated for anti-biofilm, LPS-neutralizing, and immunomodulatory research applications.

• Enhanced Antifungal Activity via 13-Benzyl Berberrubine Deri

  2026-07-04

  The reference study reports the synthesis of novel 13-(substituted benzyl) berberine and berberrubine derivatives with improved antifungal activity against clinically relevant fungi. This structure-activity relationship work advances the design of isoquinoline alkaloids, informing future research into multi-target antifungal agents.

• Ibuprofen Toxicology and Biodegradation: Environmental Impli

  2026-07-03

  This review addresses the environmental challenges posed by widespread ibuprofen use, highlighting its persistence as a contaminant and the limited effectiveness of current removal strategies. The paper emphasizes the urgent need for improved biodegradation approaches and underscores the compound's biochemical properties that complicate environmental remediation.

• Forskolin: Advancing cAMP Signaling from Mechanism to Medici

  2026-07-03

  This thought-leadership article explores how Forskolin, a direct adenylate cyclase activator, drives innovation in translational research. Blending mechanistic insights with hands-on protocol guidance and cross-domain relevance, we link foundational cAMP biology to state-of-the-art human neuron models, regenerative medicine, and disease modeling—including new evidence on HSV-1 reactivation. We compare APExBIO’s Forskolin to conventional tools, propose strategic best practices, and offer a mature, forward-looking perspective for translational scientists.

• Gamma-linolenic Acid (GLA): Translational Insights for Infla

  2026-07-02

  Explore the multifaceted roles of Gamma-linolenic acid (GLA) in anti-inflammatory research and immune modulation. This article delivers a deep scientific perspective, practical assay strategies, and unique insights into GLA’s translational impact on inflammation and humoral immunity.

• Tanshinone IIA Inhibits Key Psoriasis Pathways: Mechanistic

  2026-07-02

  This study demonstrates that Tanshinone IIA, a component of Xiao-Yin decoction, alleviates psoriasis by suppressing IL-17/IL-23 and PTGS2/NF-κB/AP-1 signaling in keratinocytes and mouse models. The findings establish mechanistic evidence for the anti-inflammatory and anti-proliferative effects of Tanshinone IIA, with implications for optimizing combinatorial and targeted therapeutic strategies in inflammatory skin disease.

• CHI3L1-IN-5 (Compound Z17): Advanced Neuroinflammation Workf

  2026-07-01

  CHI3L1-IN-5 (Compound Z17) delivers precise CHI3L1 inhibition and robust CNS penetration for advanced neurodegeneration models. This article translates structure-activity breakthroughs and peer-reviewed protocols into actionable workflow strategies, troubleshooting, and assay optimization for Alzheimer's and neuroinflammation research.

15507 records 1/1034 page Next 12345 下5页 Last page